Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > HLVX HilleVax > Detailed Quotes

HLVX HilleVax

Watchlist
13.320
+0.640+5.05%
Close 08/08 16:00 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
13.440
Open
12.140
Turnover
404.23K
Low
12.140
Pre Close
12.680
Volume
30.64K
Market Cap
445.25M
P/E(TTM)
Loss
52wk High
20.950
Shares
33.43M
P/E(Static)
Loss
52wk Low
7.900
Float Cap
180.22M
Bid/Ask %
100.00%
Historical High
20.950
Shs Float
13.53M
Volume Ratio
0.49
Historical Low
7.900
Dividend TTM
--
Div Yield TTM
--
P/B
-2.64
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.23%
Amplitude
10.25%
Avg Price
13.191
Lot Size
1
Float Cap
180.22M
Bid/Ask %
100.00%
Historical High
20.950
Shs Float
13.53M
Volume Ratio
0.49
Historical Low
7.900
Dividend TTM
--
P/B
-2.64
Dividend LFY
--
Turnover Ratio
0.23%
Amplitude
10.25%
Avg Price
13.191
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
CEO: Hershberg M.D., Ph.D., Robert M.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top